Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.438 USD | +1.60% | +7.59% | -4.80% |
Mar. 20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
Mar. 18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
Financials (USD)
Sales 2024 * | 2.42M | Sales 2025 * | 14.18M | Capitalization | 32.45M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -82M | EV / Sales 2024 * | 13.1 x |
Net cash position 2024 * | 788K | Net Debt 2025 * | 25.13M | EV / Sales 2025 * | 4.06 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.41
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.56% |
Latest transcript on Singular Genomics Systems, Inc.
1 day | +1.60% | ||
1 week | +7.59% | ||
Current month | +9.23% | ||
1 month | -10.45% | ||
3 months | -25.76% | ||
6 months | -24.48% | ||
Current year | -4.80% |
Managers | Title | Age | Since |
---|---|---|---|
Eli Glezer
FOU | Founder | 55 | 16-05-31 |
Andrew Spaventa
CEO | Chief Executive Officer | 39 | 16-05-31 |
Dalen Meeter
DFI | Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Barker
FOU | Founder | 82 | 16-08-31 |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-04-30 |
Michael Pellini
BRD | Director/Board Member | 58 | 17-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +8.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.438 | +1.60% | 68,878 |
24-05-07 | 0.4311 | -0.21% | 77,706 |
24-05-06 | 0.432 | +4.58% | 739,942 |
24-05-03 | 0.4131 | +3.28% | 81,842 |
24-05-02 | 0.4 | -1.74% | 178,483 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.80% | 31.94M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- OMIC Stock